Surgical and endovascular revision of infrainguinal vein bypass grafts: Analysis of midterm outcomes from the PREVENT III trial

Journal of Vascular Surgery

Volumn 46, Issue 6, 2007, Pages

  Berceli, Scott A ^a   Hevelone, Nathanael D ^b   Lipsitz, Stuart R ^b   Bandyk, Dennis F ^c   Clowes, Alexander W ^d   Moneta, Gregory L ^e   Conte, Michael S ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMPUTATION; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; GRAFT OCCLUSION; HAZARD RATIO; HOSPITALIZATION; HUMAN; INFRAINGUINAL VEIN BYPASS GRAFT; INTERVENTION STUDY; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; TREATMENT FAILURE; ULTRASOUND SURVEILLANCE; VASCULAR SURGERY; VEIN GRAFT;

EID: 37249002836     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.07.049     Document Type: Article

References (20)

1. Caps M.T., Cantwell-Gab K., Bergelin R.O., and Strandness Jr. D.E. Vein graft lesions: time of onset and rate of progression. J Vasc Surg 22 (1995) 466-474
2. Mills Sr. J.L., Wixon C.L., James D.C., Devine J., Westerband A., and Hughes J.D. The natural history of intermediate and critical vein graft stenosis: recommendations for continued surveillance or repair. J Vasc Surg 33 (2001) 273-278
3. Rhodes J.M., Gloviczki P., Bower T.C., Panneton J.M., Canton L.G., and Toomey B.J. The benefits of secondary interventions in patients with failing or failed pedal bypass grafts. Am J Surg 178 (1999) 151-155
4. Pomposelli F.B., Kansal N., Hamdan A.D., et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 37 (2003) 307-315
5. Shah D.M., Darling III R.C., Chang B.B., Fitzgerald K.M., Paty P.S., and Leather R.P. Long-term results of in situ saphenous vein bypass. Analysis of 2058 cases. Ann Surg 222 (1995) 438-446
6. Conte M.S., Bandyk D.F., Clowes A.W., et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 43 (2006) 742-751
7. Carlson G.A., Hoballah J.J., Sharp W.J., et al. Balloon angioplasty as a treatment of failing infrainguinal autologous vein bypass grafts. J Vasc Surg 39 (2004) 421-426
8. Nehler M.R., Moneta G.L., Yeager R.A., Edwards J.M., Taylor Jr. L.M., and Porter J.M. Surgical treatment of threatened reversed infrainguinal vein grafts. J Vasc Surg 20 (1994) 558-563
9. Avino A.J., Bandyk D.F., Gonsalves A.J., et al. Surgical and endovascular intervention for infrainguinal vein graft stenosis. J Vasc Surg 29 (1999) 60-70
10. Eagleton M.J., Erez O., Srivastava S.D., et al. Outcome of surgical and endoluminal intervention for infrainguinal bypass anastomotic strictures. Vasc Endovascular Surg 40 (2006) 11-22
11. Conte M.S., Bandyk D.F., Clowes A.W., Moneta G.L., Namini H., and Seely L. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg 42 (2005) 456-464
12. Conte M.S., Lorenz T.J., Bandyk D.F., Clowes A.W., Moneta G.L., and Seely B.L. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovascular Surg 39 (2005) 15-23
13. Nguyen L.L., Conte M.S., Menard M.T., et al. Infrainguinal vein bypass graft revision: factors affecting long-term outcome. J Vasc Surg 40 (2004) 916-923
14. Nguyen L.L., Moneta G.L., Conte M.S., Bandyk D.F., Clowes A.W., and Seely B.L. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg 44 (2006) 977-983
15. Bandyk D.F., Bergamini T.M., Towne J.B., Schmitt D.D., and Seabrook G.R. Durability of vein graft revision: the outcome of secondary procedures. J Vasc Surg 13 (1991) 200-208
16. Landry G.J., Moneta G.L., Taylor Jr. L.M., Edwards J.M., Yeager R.A., and Porter J.M. Long-term outcome of revised lower-extremity bypass grafts. J Vasc Surg 35 (2002) 56-62
17. Landry G.J., Moneta G.L., Taylor Jr. L.M., Edwards J.M., and Yeager R.A. Comparison of procedural outcomes after lower extremity reversed vein grafting and secondary surgical revision. J Vasc Surg 38 (2003) 22-28
18. Alexander J.Q., and Katz S.G. The efficacy of percutaneous transluminal angioplasty in the treatment of infrainguinal vein bypass graft stenosis. Arch Surg 138 (2003) 510-513
19. Perler B.A., Osterman F.A., Mitchell S.E., Burdick J.F., and Williams G.M. Balloon dilatation versus surgical revision of infra-inguinal autogenous vein graft stenoses: long-term follow-up. J Cardiovasc Surg (Torino) 31 (1990) 656-661
20. Abbruzzese T.A., Havens J., Belkin M., et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg 39 (2004) 1178-1185